Cart
sales@molnova.com
WAY-303290
CAS No. 323176-64-3
WAY-303290( —— )
Catalog No. M28862 CAS No. 323176-64-3
WAY-303290 inhibits the pY binding site of tyrosine kinase p56lck SH2 domain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 56 | In Stock |
|
| 2MG | 30 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 79 | In Stock |
|
| 25MG | 133 | In Stock |
|
| 50MG | 193 | In Stock |
|
| 100MG | 288 | In Stock |
|
| 200MG | 403 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-303290
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-303290 inhibits the pY binding site of tyrosine kinase p56lck SH2 domain.
-
DescriptionWAY-303290 inhibits the pY binding site of tyrosine kinase p56lck SH2 domain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetSrc
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number323176-64-3
-
Formula Weight302.78
-
Molecular FormulaC15H11ClN2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(c(sc1c2cccc1)c2Cl)NCc1cnccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Slee AM, et al. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrob Agents Chemother. 1987 Nov;31(11):1791-7.
molnova catalog
related products
-
KB SRC 4
KB SRC 4 is a selective and potent c-Src inhibitor with antitumour activity that inhibits the growth of cancer cells.
-
AD57
AD57 is a potent inhibitor of both c-Src and Abl with IC50 of 0.025 μM and 0.041 μM, respectively.
-
CpCDPK1/TgCDPK1-IN-1
CpCDPK1/TgCDPK1-IN-1 is a potent dual inhibitor of CpCDPK1 and TgCDPK1, inhibits Abl and Src, and has antiparasitic activity for the study of Toxoplasma infections and cryptosporidiosis.
